HOME › Press Releases › Cell Analysis Market worth USD 26.0 Billion USD by 2020
Cell Analysis Market worth USD 26.0 Billion USD by 2020
The report "Cell Analysis Market by Product (Instrument (PCR, HCS, Spectrophotometer, Microscope), & Consumables (Assay, Reagent)), by Process (Cell Proliferation, Single Cell Analysis), & by End User (Hospital, Pharmaceutical, Biotechnology, CRO) - Forecast to 2020", provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the cell Analysis market along with the estimates and forecasts of the revenue and share analysis.
Browse 289 market tables and 39 figures spread through 277 pages and in-depth TOC on "Cell Analysis Market by Product (Instrument (PCR, HCS, Spectrophotometer, Microscope), & Consumables (Assay, Reagent)), by Process (Cell Proliferation, Single Cell Analysis), & by End User (Hospital, Pharmaceutical, Biotechnology, CRO) - Forecast to 2020"
Early buyers will receive 10% customization on reports.
The global cell Analysis market is expected to reach USD 26.0 Billion by 2020 from USD 19.0 Billion in 2015, growing at a CAGR of 6.56% from 2015 to 2020.
The report segments this market on the basis of product, process, and end user. Among products, the consumables is expected to account for the largest share in 2015, while instruments is expected to be the fastest-growing segment in the cell Analysis market, owing to technological advancement due to which new products are being launched in the market. Furthermore, rising applications of cell Analysis processed in drug discovery and cancer research is another major reason for the growth of this market.
Based on geography, the global cell Analysis market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is expected to account for the largest share of the market in 2015. The large share of this region can be attributed to various factors including increasing government support for cancer and stem cell research and well establsihed biotechnology and biopharmaceutical industries in this region.
Prominent players in the cell analysis market are Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), Danaher Corporation (U.S.), GE Corporation (U.K.), Olympus Corporation (Japan), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), and Tecan Group Ltd. (Switzerland).
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India